Skip to Content

150 GG 338 (Levothyroxine 150 mcg (0.15 mg))

Pill imprint 150 GG 338 has been identified as Levothyroxine sodium 150 mcg (0.15 mg).

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 150 mcg (0.15 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Levothyroxine sodium 150 mcg (0.15 mg) 150 GG 338 Front
Levothyroxine sodium 150 mcg (0.15 mg) 150 GG 338 Back
Levothyroxine sodium 150 mcg (0.15 mg) 150 GG 338
Levothyroxine sodium 150 mcg (0.15 mg) 150 GG 338
Levothyroxine sodium
150 GG 338
150 mcg (0.15 mg)
9.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-1093 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.